Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Share-based Compensation (2024 - 2025)

Historic Share-based Compensation for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to $4.5 million.

  • Beta Bionics' Share-based Compensation rose 12661.94% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.6 million, marking a year-over-year change of. This contributed to the annual value of $6.4 million for FY2024, which is 1283.14% up from last year.
  • According to the latest figures from Q3 2025, Beta Bionics' Share-based Compensation is $4.5 million, which was up 12661.94% from $4.8 million recorded in Q2 2025.
  • Over the past 5 years, Beta Bionics' Share-based Compensation peaked at $4.8 million during Q2 2025, and registered a low of $1.4 million during Q1 2024.